ROLE SUMMARY
The PHE Lead (Patient Healthcare Experience Lead) is a critical enablement role whose primary responsibility is to drive and advance cross-brand impact through data and insights-driven transformation strategies. S/he is expected to optimize channel management and channel investment mix to differentiate Pfizer brand through deep customer loyalty.
The focus of this role is to manage cross portfolio channels outside of CFC (Customer Facing Colleagues) and share a pro-active voice to drive value, uptake and customer engagement.
There will be a component of the role to drive up-take of Pfizer owned channels , especially to optimize field force. The role will focus less on CFC optimization but more on building other channels to take up customer engagement based on data.
ROLE RESPONSIBILITIES
  • Connector between local critical business needs and Global Marketing /Regional Commercial Organization, driving optimization and standardization when it is needed.
  • Leads cross-brand Patient Experience & Engagement and optimizes Patient Support Programs operations.
  • Bring customer insights and data to drive investments that deliver maximized growth and revenue opportunities thru strong commercial acumen and leadership
  • Work with design thinking principles, maximizing omnichannel impact and all digital platforms including AI and other cutting-edge technologies to advance customer/patient impact
  • Navigate, influence and manage across multiple internal engagement channels including content & media buying agency, 3rd party partnerships, to advance the channel strategy
Scope of Projects:
  • Drives key marketing execution projects (New Way of Working & facilitate with global agency).
  • Accelerates innovation and provides data visibility for performance improvement in projects that touch both marketing and sales.
  • Marketing led: Omnichannel Experience & Insights, Content Process Effectiveness, Channel Management
  • Sales led: Effective adoption of DSP (Digital Sales Presentation), CFC Messaging, and Rep- Trigger Email, focused on productive and quality HCP visits.
BASIC QUALIFICATIONS
  • Digital Marketing / Data Analytics Savviness
  • Innovation / Growth mindset
  • Outcome-driven
  • Ability to synthesize and communicate data/insights
  • Ability to influence without authority
  • Lead Transformation & Change Management
  • Navigate / orchestrate the matrix organization
  • Leader - Integrity & Compliance
  • Customer Excellence – proven experience leading and managing cross brand transformations to maximise customer engagement to differentiate Pfizer brand.
  • Performance Excellence – Omnichannel expert with deep experience in translating channel performance outcomes to key customer insights to differentiate investment strategies for the markets.
  • Commercial Experience – business acumen and experience making commercial decisions using insights-based inputs.
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
Mkt & Sales/Commercial Bus
āļ›āļĢāļ°āļŠāļšāļāļēāļĢāļ“āđŒāļ—āļĩāđˆāļˆāļģāđ€āļ›āđ‡āļ™
  • āđ„āļĄāđˆāļĢāļ°āļšāļļāļ›āļĢāļ°āļŠāļšāļāļēāļĢāļ“āđŒāļ‚āļąāđ‰āļ™āļ•āđˆāļģ
āđ€āļ‡āļīāļ™āđ€āļ”āļ·āļ­āļ™
  • āļŠāļēāļĄāļēāļĢāļ–āļ•āđˆāļ­āļĢāļ­āļ‡āđ„āļ”āđ‰
āļŠāļēāļĒāļ‡āļēāļ™
  • āļāļēāļĢāļ•āļĨāļēāļ” / āđ‚āļ†āļĐāļ“āļē
  • āļāļĨāļĒāļļāļ—āļ˜āđŒ / āļ§āļēāļ‡āđāļœāļ™
āļ›āļĢāļ°āđ€āļ āļ—āļ‡āļēāļ™
  • āļ‡āļēāļ™āļ›āļĢāļ°āļˆāļģ

āđ€āļāļĩāđˆāļĒāļ§āļāļąāļšāļšāļĢāļīāļĐāļąāļ—

āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™:100-500 āļ„āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļšāļĢāļīāļĐāļąāļ—:āļāļēāļĢāđāļžāļ—āļĒāđŒ / āđ€āļ āļŠāļąāļŠāļāļĢāļĢāļĄ
āļ—āļĩāđˆāļ•āļąāđ‰āļ‡āļšāļĢāļīāļĐāļąāļ—:āļāļĢāļļāļ‡āđ€āļ—āļž
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒ:www.pfizer.co.th
āļāđˆāļ­āļ•āļąāđ‰āļ‡āđ€āļĄāļ·āđˆāļ­āļ›āļĩ:1958

Pfizer āļ•āđ‰āļ­āļ‡āļāļēāļĢāļŠāđˆāļ§āļĒāđƒāļŦāđ‰āļœāļđāđ‰āļ„āļ™āđƒāļ™āđ‚āļĨāļāļĄāļĩāļŠāļļāļ‚āļ āļēāļžāļ”āļĩāļĒāļīāđˆāļ‡āļ‚āļķāđ‰āļ™ Pfizer āļĒāļīāļ™āļ”āļĩāļ•āđ‰āļ­āļ™āļĢāļąāļšāđ€āļžāļ·āđˆāļ­āļ™āļĢāđˆāļ§āļĄāļ‡āļēāļ™āļˆāļēāļāļ—āļļāļāļĄāļļāļĄāđ‚āļĨāļ â€“ āđ„āļĄāđˆāļ§āđˆāļēāļˆāļ°āđ€āļ›āđ‡āļ™āļŠāļēāļ™āđ€āļĄāļ·āļ­āļ‡āļ‚āļ­āļ‡āđ€āļĄāļ·āļ­āļ‡āļ—āļĩāđˆāđ€āļĨāđ‡āļāļ—āļĩāđˆāļŠāļļāļ”āđƒāļ™āļ­āđ€āļĄāļĢāļīāļāļē āļŦāļĄāļđāđˆāļšāđ‰āļēāļ™āđƒāļ™āđ€āļĒāļ­āļĢāļĄāļ™āļĩ āļŦāļĢāļ·āļ­āđ€āļĄāļ·āļ­āļ‡āļ—āļĩāđˆāļ—āļąāļ™āļŠāļĄāļąāļĒāļ—āļĩāđˆāļŠāļļāļ”āđƒāļ™āļˆāļĩāļ™āļāđ‡āļ•āļēāļĄ āđ€āļĢāļēāđ€āļŠāļ·āđˆāļ­āļ§āđˆāļēāļ›āļĢāļ°āļŠāļšāļāļēāļĢāļ“āđŒāļŠāļĩāļ§āļīāļ•āļ—āļĩāđˆāđ„āļĄāđˆāđ€āļŦāļĄāļ·āļ­āļ™āļāļąāļ™āļ‚āļ­āļ‡āđāļ•āđˆāļĨāļ°āļ„āļ™āļŠāļēāļĄāļēāļĢāļ–āđ€āļ›āđ‡āļ™āļŠāđˆāļ§āļ™āļœāļŠāļĄāļ—āļĩāđˆāļĨāļ‡āļ•āļąāļ§āļŠāļģāļŦāļĢāļąāļš Pfizer ...

āļ­āđˆāļēāļ™āļ•āđˆāļ­

āļĢāđˆāļ§āļĄāļ‡āļēāļ™āļāļąāļšāđ€āļĢāļē:

āđ‚āļ­āļāļēāļŠāļ‚āļ­āļ‡āļ„āļļāļ“āđƒāļ™āļāļēāļĢāļŠāļĢāđ‰āļēāļ‡āļœāļĨāļāļĢāļ°āļ—āļšāđ€āļŠāļīāļ‡āļšāļ§āļāļ—āļąāđˆāļ§āđ‚āļĨāļāđ€āļĢāļīāđˆāļĄāļ•āđ‰āļ™āļ—āļĩāđˆāļ™āļĩāđˆ āđ„āļĄāđˆāļ§āđˆāļēāļ„āļļāļ“āļˆāļ°āđ€āļ›āđ‡āļ™āļœāļđāđ‰āļŦāļēāļ‡āļēāļ™āļ—āļĩāđˆāļĄāļĩāļ›āļĢāļ°āļŠāļšāļāļēāļĢāļ“āđŒāđƒāļ™āļāļēāļĢāļ—āļģāļ‡āļēāļ™ āļŦāļĢāļ·āļ­āđ€āļ›āđ‡āļ™āļĄāļ·āļ­āđƒāļŦāļĄāđˆāđƒāļ™āļŠāļēāļ‚āļēāļ™āļĩāđ‰ āđ‚āļ­āļāļēāļŠāļ”āđ‰āļēāļ™āļ­āļēāļŠāļĩāļžāļĢāļ°āļ”āļąāļšāđ‚āļĨāļāđƒāļ™āļ˜āļļāļĢāļāļīāļˆāļŦāļĨāļēāļĒāļŠāļēāļ‚āļēāļ‚āļ­āļ‡āđ€āļĢāļēāļžāļĢāđ‰āļ­āļĄāđāļĨāđ‰āļ§āļŠāļģāļŦāļĢāļąāļšāļ„āļļāļ“

āļŠāļģāļ™āļąāļāļ‡āļēāļ™āđƒāļŦāļāđˆ: āļŠāļąāđ‰āļ™ 36 āđāļĨāļ° 37 āļ­āļēāļ„āļēāļĢāļĒāļđāđ„āļ™āđ€āļ•āđ‡āļ” āđ€āļ‹āđ‡āļ™āđ€āļ•āļ­āļĢāđŒ 323 āļ–āļ™āļ™āļŠāļĩāļĨāļĄ āđāļ‚āļ§āļ‡āļŠāļĩāļĨāļĄ āđ€āļ‚āļ•āļšāļēāļ‡āļĢāļąāļ āļāļĢāļļāļ‡āđ€āļ—āļžāļŊ 10500
Display map

āļŠāļ§āļąāļŠāļ”āļīāļāļēāļĢ

  • āļ›āļĢāļ°āļāļąāļ™āļŠāļąāļ‡āļ„āļĄ
  • āļāļēāļĢāļžāļąāļ’āļ™āļēāđ€āļžāļ·āđˆāļ­āļ„āļ§āļēāļĄāđ€āļ›āđ‡āļ™āļĄāļ·āļ­āļ­āļēāļŠāļĩāļž
  • āđ‚āļ­āļāļēāļŠāđƒāļ™āļāļēāļĢāđ€āļĢāļĩāļĒāļ™āļĢāļđāđ‰āđāļĨāļ°āļžāļąāļ’āļ™āļē
  • āļāļķāļāļ­āļšāļĢāļĄ

āļ•āļģāđāļŦāļ™āđˆāļ‡āļ‡āļēāļ™āļ§āđˆāļēāļ‡āļ—āļĩāđˆāļ„āļļāļ“āļ™āđˆāļēāļˆāļ°āļŠāļ™āđƒāļˆ

āļ”āļđāļ‡āļēāļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ” >

āļ—āļĩāđˆ WorkVenture āđ€āļĢāļēāđƒāļŦāđ‰āļĄāļđāļĨāđ€āļŠāļīāļ‡āđ€āļāļĩāđˆāļĒāļ§āļāļąāļšāļšāļĢāļīāļĐāļąāļ— āđ„āļŸāđ€āļ‹āļ­āļĢāđŒ (āļ›āļĢāļ°āđ€āļ—āļĻāđ„āļ—āļĒ) āļˆāļģāļāļąāļ” āđ‚āļ”āļĒāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡ āļ•āļąāđ‰āļ‡āđāļ•āđˆāļ āļēāļžāļšāļĢāļĢāļĒāļēāļāļēāļĻāļāļēāļĢāļ—āļģāļ‡āļēāļ™ āļĢāļđāļ›āļ–āđˆāļēāļĒāļ‚āļ­āļ‡āļ—āļĩāļĄāļ‡āļēāļ™ āđ„āļ›āļˆāļ™āļ–āļķāļ‡āļĢāļĩāļ§āļīāļ§āđ€āļŠāļīāļ‡āļĨāļķāļāļ‚āļ­āļ‡āļāļēāļĢāļ—āļģāļ‡āļēāļ™āļ—āļĩāđˆāļ™āļąāđˆāļ™ āļ‹āļķāđˆāļ‡āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļļāļāļ­āļĒāđˆāļēāļ‡āļšāļ™āļŦāļ™āđ‰āļēāļ‚āļ­āļ‡āļšāļĢāļīāļĐāļąāļ— āđ„āļŸāđ€āļ‹āļ­āļĢāđŒ (āļ›āļĢāļ°āđ€āļ—āļĻāđ„āļ—āļĒ) āļˆāļģāļāļąāļ” āļĄāļĩāļžāļ™āļąāļāļ‡āļēāļ™āļ—āļĩāđˆāļāļģāļĨāļąāļ‡āļ—āļģāļ‡āļēāļ™āļ—āļĩāđˆāļšāļĢāļīāļĐāļąāļ— āđ„āļŸāđ€āļ‹āļ­āļĢāđŒ (āļ›āļĢāļ°āđ€āļ—āļĻāđ„āļ—āļĒ) āļˆāļģāļāļąāļ” āļŦāļĢāļ·āļ­āđ€āļ„āļĒāļ—āļģāļ‡āļēāļ™āļ—āļĩāđˆāļ™āļąāđˆāļ™āļˆāļĢāļīāļ‡āđ† āđ€āļ›āđ‡āļ™āļ„āļ™āđƒāļŦāđ‰āļ‚āđ‰āļ­āļĄāļđāļĨāļˆāļĢāļīāļ‡āļŠāļĄāļąāļ„āļĢāļ‡āļēāļ™ āļšāļĢāļīāļĐāļąāļ— āđ€āļ—āđ€āļĨāđ€āļžāļ­āļĢāđŒāļŸāļ­āļĢāđŒāļĄāļēāļ™āļ‹āđŒ āļ›āļĢāļ°āđ€āļ—āļĻāđ„āļ—āļĒ āļˆāļģāļāļąāļ”āļŠāļĄāļąāļ„āļĢāļ‡āļēāļ™ āļ”āļēāđ€āļŦāļĨāļĩāļĒāļ™ āđ€āļŠāļ‡āļ‹āļĩāļŠāļĄāļąāļ„āļĢāļ‡āļēāļ™ āļ‹āļđāļ‹āļđāđ‚āļĒāļŠāļĄāļąāļ„āļĢāļ‡āļēāļ™ āđāļŪāļ›āļ›āļĩāđ‰āđ€āļŸāļĢāļŠ